Pyroptosis has emerged as a key pathological process in IIM, with NLRP3 and AIM2 inflammasomes, caspases, and gasdermin proteins playing central roles, which may offer new therapeutic strategies for IIM. The gene discussed is AIM2; the disease is acquired idiopathic inflammatory myopathy.